Sources: STEP 1 Trial, Wegovy prescribing information, Novo Nordisk
Non-Sterile Equipment: Reusing needles, syringes, or other tools, or using equipment that has not been properly sterilized
Fat mobilisation and fat oxidation
The dose doubling produces a temporary return of: Nausea usually for 35 days post-injection Increased fullness and reduced appetite meals may feel impossible to finish Possible reflux or Ozempic burps (sulphurous belching) Fatigue or brain fog How to manage: Eat smaller, more frequent meals 45 per day, not 3 large Stop eating at the first feeling of fullness Stay upright for 30 minutes after eating Try ginger tea or ginger capsules evidence supports anti-nausea effects: ginger and nausea, PMC Weeks 78 Second Adaptation Window Dose: still 0.5 mg By the end of week 8, most patients have stabilised again
If the solution becomes unexpectedly cloudy, develops discoloration, or contains foreign particulate matter that does not dissolve, the material should not be used for laboratory experiments until the cause has been determined
Prepare the needle (Ozempic and compounded semaglutide only)
